Blog
Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readouts
Key Points
- Interested in Karyopharm Therapeutics Inc.? Here are five stocks we like better.
- Karyopharm highlighted upcoming milestones for selinexor, including an ASCO late-breaking
Alphabet Just Unveiled Its Most Ambitious AI Lineup Yet
Key Points
- Interested in Alphabet Inc.? Here are five stocks we like better.
- At Google I/O 2026, Alphabet unveiled a suite of new AI models and features, including Gemini 3.5 Flash, Omni, and
Atalaya Mining Q1 Earnings Call Highlights
Key Points
- Interested in Atalaya Mining Plc? Here are five stocks we like better.
- Q1 production was hit by heavy rain in Spain, but Atalaya still generated €14 million of EBITDA and nearly €30
Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus
Key Points
- Interested in Karyopharm Therapeutics Inc.? Here are five stocks we like better.
- Karyopharm said it will present fuller Phase 3 SENTRY data for selinexor in newly diagnosed
KLA Flags Stronger Chip Equipment Demand, Rare 2027 Visibility at JPMorgan Conference
Key Points
- Interested in KLA Corporation? Here are five stocks we like better.
- KLA said semiconductor equipment demand is strengthening across leading-edge logic, memory and advanced
J.B. Hunt Highlights Intermodal Share Gains, Pricing Upside at Wolfe Conference
Key Points
- Interested in J.B. Hunt Transport Services, Inc.? Here are five stocks we like better.
- Intermodal demand is steady, but J.B. Hunt said recent volume gains are being driven more by
Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges
Key Points
- Interested in Disc Medicine, Inc.? Here are five stocks we like better.
- Disc Medicine said enrollment in its APOLLO confirmatory study for bitopertin in EPP reached 183 patients
JOYY Q1 Earnings Call Highlights
Key Points
- Interested in JOYY Inc.? Here are five stocks we like better.
- JOYY posted strong Q1 2026 results, with total net revenue up 12.4% year over year to $555.7 million and non-GAAP
Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst
Key Points
- Interested in Opus Genetics, Inc.? Here are five stocks we like better.
- Opus Genetics highlighted a broad inherited retinal disease gene therapy pipeline, with two programs already
PPDAI Group Q1 Earnings Call Highlights
Key Points
- Interested in PPDAI Group Inc. Sponsored ADR? Here are five stocks we like better.
- FinVolution posted a steady first quarter of 2026, with net revenue up 6% sequentially to RMB 3.2
Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 Readouts
Key Points
- Interested in Ionis Pharmaceuticals, Inc.? Here are five stocks we like better.
- Ionis has a packed 2026-style catalyst calendar with two PDUFA dates for wholly owned drugs —
Intel CEO Touts Balance Sheet Progress, Foundry Gains and AI CPU Demand
Key Points
- Interested in Intel Corporation? Here are five stocks we like better.
- CEO Lip-Bu Tan said Intel has made early progress on strengthening its balance sheet, improving execution, and
Intapp Says AI Is Driving Demand as Celeste Tackles Compliance Risks
Key Points
- Interested in Intapp, Inc.? Here are five stocks we like better.
- AI is becoming a growth driver for Intapp as professional-services firms look for ways to automate work without
Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances
Key Points
- Interested in Inovio Pharmaceuticals, Inc.? Here are five stocks we like better.
- Shareholders approved all proposals at Inovio’s 2026 annual meeting, including the election of eight
Incyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll Out
Key Points
- Interested in Incyte Corporation? Here are five stocks we like better.
- Incyte plans to start a Phase 3 trial of mutant CALR antibody 989 in essential thrombocythemia around
SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
Key Points
- Interested in Redwire Corporation? Here are five stocks we like better.
- Luke Lango of InvestorPlace argues that Tesla, SpaceX, X, and XAI are converging into a single AI-driven empire
Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
Key Points
- Interested in Ralph Lauren Corporation? Here are five stocks we like better.
- As apparel companies reported their financial results, three names stood out.
- Notably, Ralph Lauren shares
LexinFintech Q1 Earnings Call Highlights
Key Points
- Interested in LexinFintech Holdings Ltd. Sponsored ADR? Here are five stocks we like better.
- LexinFintech posted higher Q1 loan volume and revenue, with total loan volume up 15.9%
Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Key Points
- Interested in Walmart Inc.? Here are five stocks we like better.
- Despite all three posting solid results, TJX Companies rose 5.6% after earnings, while Walmart fell 7.3% and Target
The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear
Key Points
- Interested in Target Corporation? Here are five stocks we like better.
- Walmart, Home Depot, and other retailers say consumers remain active but increasingly price-sensitive.
Ross Stores Earnings Beat Sends Stock To New Highs
Key Points
- Interested in Ross Stores, Inc.? Here are five stocks we like better.
- Ross Stores delivered another strong earnings beat in the first quarter, as broad-based customer traffic growth
IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing
Key Points
- Interested in IDEAYA Biosciences, Inc.? Here are five stocks we like better.
- Darovasertib, IDEAYA’s lead drug, posted strong Phase I/II results in first-line HLA-A2 negative
InterDigital Eyes $1B ARR by 2030 as 6G, AI Video and Patent Push Take Center Stage
Key Points
- Interested in InterDigital, Inc.? Here are five stocks we like better.
- InterDigital is targeting more than $1 billion in annual recurring revenue by 2030, up from about $560 million
IAC Conference Highlights People Inc. Pivot, AI Licensing Upside and MGM Bet
Key Points
- Interested in IAC Inc.? Here are five stocks we like better.
- IAC is simplifying into People Inc. Executives said the company has narrowed its structure after spinning off Angi
Horizon Quantum Computing Pte. CEO Says Software Is Key to Quantum's Next Leap
Key Points
- Interested in Horizon Quantum Computing Pte. Ltd.? Here are five stocks we like better.
- Horizon Quantum Computing is pitching itself as a software-first quantum company, with CEO